Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Gelenberg

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Report by the ACNP Task Force on response and remission in major depressive disorderA John Rush, Helena C Kraemer, Harold A Sackeim, et al.
Archives of General Psychiatry|March 7, 2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depressionMichael E Thase, A John Rush, Robert H Howland, et al.
The Journal of Clinical Psychiatry|August 25, 2004
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg, Richard C Shelton, Paul Crits-Christoph, et al.
American Journal of Preventive Medicine|April 21, 2012
Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysisAnilkrishna B Thota, Theresa Ann Sipe, Guthrie J Byard, et al.
American Journal of Preventive Medicine|May 23, 2015
Effects of mental health benefits legislation: a community guide systematic reviewTheresa Ann Sipe, Ramona K C Finnie, John A Knopf, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
Biological Psychiatry|September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Biological Psychiatry|October 11, 2003
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionAlan J Gelenberg, Madhukar H Trivedi, A John Rush, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Report by the ACNP Task Force on response and remission in major depressive disorderA John Rush, Helena C Kraemer, Harold A Sackeim, et al.
Archives of General Psychiatry|March 7, 2002
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depressionMichael E Thase, A John Rush, Robert H Howland, et al.
The Journal of Clinical Psychiatry|August 25, 2004
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg, Richard C Shelton, Paul Crits-Christoph, et al.
American Journal of Preventive Medicine|April 21, 2012
Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysisAnilkrishna B Thota, Theresa Ann Sipe, Guthrie J Byard, et al.
American Journal of Preventive Medicine|May 23, 2015
Effects of mental health benefits legislation: a community guide systematic reviewTheresa Ann Sipe, Ramona K C Finnie, John A Knopf, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
Biological Psychiatry|September 11, 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller, Madhukar H Trivedi, Michael E Thase, et al.
Biological Psychiatry|October 11, 2003
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionAlan J Gelenberg, Madhukar H Trivedi, A John Rush, et al.
The Journal of Clinical Psychiatry|August 10, 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis, Michael E Thase, Madhukar H Trivedi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 4, 2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush, Madhukar H Trivedi, Thomas J Carmody, et al.
Pageof 8